Patient’s Qualitative Assessment of Treatment version 2 (PQATv2)

• Published in 2019
• Created from the PQATv1

Adam Gater, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal and Aude Roborel de Climens. Tell me more: Exploring patient perspective on the benefits and disadvantages of drugs during clinical trials. #84209, DIA San Diego, USA, 2019 (Poster).

Adam Gater, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal and Aude Roborel de Climens. Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire to Explore Individualized Benefit-Harm of Drugs Received During Clinical Studies: an example in type 2 diabetes mellitus. (submitted to Drug Safety)

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

• PQATv2 in English for the USA 
• PQATv1 in English for the USA

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

For information on, or permission to use the translations, please contact Mapi Research Trust